ANI Pharmaceuticals Announces Board Authorization of Stock Repurchase Program
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall St choppy as megacap losses offset chip gains before Fed decision
- SK Hynix shares surge after Q3 profit beats expectations
- Oil up 1% as Saudi Arabian refinery attack reignites supply concerns
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
- S&P Global explores potential separation of Capital IQ business
- Wall Street ends higher on revived AI momentum
- Nebius Group shares jump after France data center funding
- GE Vernova Inc. (GEV) Tops Q3 EPS by 81c, Beats on Revenue; Offers FY26 Revenue Guidance
- Seagate Technology (STX) Tops Q1 EPS by 29c, Offers Guidance
ANI Pharma (ANIP) Approves $25M Common Stock Buyback Plan
October 5, 2015 8:02 AM EDTANI Pharma (NASDAQ: ANIP) announced that its Board of Directors has authorized a stock repurchase program under which the Company may repurchase up to $25 million of shares of the Company's common stock. ANI expects to fund the stock repurchase program through cash on hand.... More



